| Sig K1-high | Sig K1-low | P valuea | |
|---|---|---|---|
| No. of patients | 28 | 28 | |
| Age, yr | 0.2847 | ||
| >60 (%) | 16 (57.1) | 11 (39.3) | |
| ≤60 (%) | 12 (42.9) | 17 (60.7) | |
| Gender | 0.1707 | ||
| Male (%) | 14 (50.0) | 20 (71.4) | |
| Female (%) | 14 (50.0) | 8 (28.6) | |
| Subtypeb | 0.0148 | ||
| ABC (%) | 16 (72.7) | 7 (33.3) | |
| GCB (%) | 6 (27.3) | 14 (66.7) | |
| Stage | 1.0000 | ||
| I–II (%) | 12 (42.9) | 13 (46.4) | |
| III–IV (%) | 16 (57.1) | 15 (53.6) | |
| Primary or relapse | 0.3516 | ||
| Primary (%) | 24 (85.7) | 27 (96.4) | |
| Relapse (%) | 4 (14.3) | 1 (3.6) | |
| HBsAg status | 0.7585 | ||
| Positive (%) | 6 (21.4) | 8 (28.6) | |
| Negative (%) | 22 (78.6) | 20 (71.4) | |
| MSIseq | 0.5279 | ||
| MSI (%) | 5 (17.9) | 8 (28.6) | |
| MSS (%) | 23 (82.1) | 20 (71.4) | |
| Treatmentb | 0.2238 | ||
| CHOP (%) | 5 (18.5) | 9 (32.1) | |
| RCHOP (%) | 22 (81.5) | 17 (60.7) |
| Sig K1-high | Sig K1-low | P value | |
|---|---|---|---|
| 28 | 28 | ||
| 0.2847 | |||
| >60 (%) | 16 (57.1) | 11 (39.3) | |
| ≤60 (%) | 12 (42.9) | 17 (60.7) | |
| 0.1707 | |||
| Male (%) | 14 (50.0) | 20 (71.4) | |
| Female (%) | 14 (50.0) | 8 (28.6) | |
| ABC (%) | 16 (72.7) | 7 (33.3) | |
| GCB (%) | 6 (27.3) | 14 (66.7) | |
| 1.0000 | |||
| I–II (%) | 12 (42.9) | 13 (46.4) | |
| III–IV (%) | 16 (57.1) | 15 (53.6) | |
| 0.3516 | |||
| Primary (%) | 24 (85.7) | 27 (96.4) | |
| Relapse (%) | 4 (14.3) | 1 (3.6) | |
| 0.7585 | |||
| Positive (%) | 6 (21.4) | 8 (28.6) | |
| Negative (%) | 22 (78.6) | 20 (71.4) | |
| 0.5279 | |||
| MSI (%) | 5 (17.9) | 8 (28.6) | |
| MSS (%) | 23 (82.1) | 20 (71.4) | |
| 0.2238 | |||
| CHOP (%) | 5 (18.5) | 9 (32.1) | |
| RCHOP (%) | 22 (81.5) | 17 (60.7) |
Values are reported as n (%) of patients unless indicated otherwise. CHOP, a chemotherapy combination of cyclophosphamide, doxorubicin hydrochloride, vincristine (Oncovin, Vincasar PFS), and prednisolone; HBsAg, hepatitis B virus surface antigen; RCHOP, a chemotherapy combination of rituximab (Rituxan) and CHOP; Sig, signature.
Fisher's exact test was used for comparison. Significant value (P < 0.05) is highlighted in bold.
The calculation was based on 43 or 53 samples with available data.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.